18 December 2019 in Bioelectromagnetics
Wireless wearable and implantable devices are continuing to grow in popularity, and as this growth occurs, so too does the need to consider the safety of such devices. Wearable and implantable devices require the transmitting and receiving of electromagnetic waves near and through the body, which at high enough exposure levels may damage proximate tissues. The specific absorption rate (SAR) is the quantity commonly used to enumerate exposure levels, and various national and international organizations have defined regulations limiting exposure to ensure safe operation. In this paper, we comprehensively review dosimetric studies reported in the literature up to the year 2019 for wearables and implants. We discuss antenna designs for wearables and implants as they relate to SAR values and field and thermal distributions in tissue, present designs that have made steps to reduce SAR, and then review SAR considerations as they relate to applied devices. As compared with previous review papers, this paper is the first review to focus on dosimetry aspects relative to wearable and implantable devices. Bioelectromagnetics. 2020;41:3–20 © 2019 The Authors. Bioelectromagnetics published by Wiley Periodicals, Inc.
5 August 2020 in IEEE Antennas and Propagation Magazine
This article provides one of the first comprehensive reviews of tissue-emulating phantoms available for the in vitro experimentation of radio-frequency (RF) antennas and other electromagnetic (EM) components. Diverse recipes and formulation approaches are available in the literature for such phantoms, but a holistic overview has yet to be reported. We review RF phantoms based on their textures (i.e., liquid, semisolid, and solid) and briefly discuss the use of readily available animal tissues for in vitro experimentation. For each phantom group, we present an overview of the various recipes and fabrication methods, specify the operating frequency range and tissue(s) they emulate, discuss the associated benefits and challenges, and summarize the wireless applications for which they have been employed to date. Further, we review various methods available in the literature to measure the electrical and thermal properties of RF phantoms as required to verify their tissue-emulating capabilities. This review creates a comprehensive resource for ongoing and future studies in the field and is intended to stimulate future research in the development of tissue-emulating phantoms and wireless RF components operating in, on, or near the body.
8 March 2019 in IEEE Journal of Electromagnetics, RF and Microwaves in Medicine and Biology
We propose a new technique for matching the high impedance of sub-cranial electrodes to wireless brain implants that is passive, highly tolerant of the dc offset voltage caused by the electrochemical reaction in the recording electrode, and complemented by an improved external interrogator design that exhibits reduced phase noise. As compared to previous wireless and batteryless brain implants, the proposed approach offers a remarkable improvement in sensitivity by 25 times. The proposed system consists of an external interrogator and a neuro-recorder implanted under the scalp. For operation, the interrogator sends a 2.4-GHz carrier signal to turn on the implant. This carrier self-biases a PNP Bipolar Junction Transistor (BJT) that enables matching to the recording electrode at frequency $f_{neuro}$ in a batteryless manner. Concurrently, the recorded neuropotentials (at frequency $f_{neuro}$ ) pass through a Schottky diode that allows them to mix with the carrier and generate a 4.8 $\text{GHz}\pm f_{neuro}$ modulated signal. The latter is then transmitted back to the interrogator for demodulation. To verify the implant's operation, in-vitro measurements are presented. Measurement results demonstrate that emulated neuropotentials as low as 200 $\mu V_{pp}$ can be detected at a 33- $\text{k}\Omega$ electrode impedance. As such, the proposed system presents a game-changing capability for a wide range of applications.
6 December 2019 in IEEE Journal of Electromagnetics, RF and Microwaves in Medicine and Biology
To reduce the amount of animal testing associated with brain-computer interfaces (BCI) therefore reducing the associated monetary cost and cost of animal lives, we report a novel in vitro test setup to validate BCIs. Past validation techniques used stand-alone 50-Ω function generators or function generators connected to high-valued resistors to replicate recording from clinical electrodes; however, neither of these two methods accounts for an electrode's complex, frequency-dependent impedance, and both underestimate the normally high electrode impedance. As such, optimizing and testing via function generators and resistors overestimates BCI sensitivity by at least 250 times and 2 times, respectively. To more closely replicate a clinical recording environment and accurately assess BCI performance, we utilize a function generator to mimic neural signals sent to a human-body-mimicking electrolyte fluid via a Pt electrode. These signals are then recorded via a neural electrode connected to the BCI under test. To validate the proposed method, we compare sensitivity of a previously reported fully passive BCI via the three methods. The presented results demonstrate that recording via the proposed clinically accurate setup when the BCI has been optimized with one of the two other test methods gives the lowest sensitivity in the frequency domain and worst signal stability in the time domain. Overestimating BCI sensitivity during in vitro testing results in the potential inability to record desired neural signals in vivo . The proposed method provides a means by which to accurately assess BCI performance, therefore reducing errors during animal trials and saving time, money, and lives.